title: Diagnostic and therapeutic challenges.
authors.forename: Jesse J
authors.initials: JJ
authors.lastname: Jung
authors.forename: Tatyana
authors.initials: T
authors.lastname: Milman
authors.forename: Kimberly J
authors.initials: KJ
authors.lastname: Chin
authors.forename: Paul T
authors.initials: PT
authors.lastname: Finger
authors.forename: Alexander
authors.initials: A
authors.lastname: Aizman
authors.forename: Robert N
authors.initials: RN
authors.lastname: Johnson
mesh_terms: D018951:Antigens, CD20 / Q000378:metabolism; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000378:metabolism / Q000473:pathology; D001706:Biopsy; D017252:CD3 Complex / Q000378:metabolism; D003937:Diagnosis, Differential; D005128:Eye Diseases / Q000175:diagnosis; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D019572:Retinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D013601:T-Lymphocytes / Q000378:metabolism / Q000473:pathology; D014821:Vitrectomy; D014822:Vitreous Body / Q000473:pathology
chemical_list: D018951:Antigens, CD20; D000964:Antimetabolites, Antineoplastic; D017252:CD3 Complex; D008727:Methotrexate